Lv31
248 积分 2024-04-26 加入
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
5小时前
已完结
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
17天前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
26天前
已完结
Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice
1个月前
已完结
Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis
1个月前
已关闭
Targeted In Vivo Generation of CAR T and NK Cells Utilizing an Engineered Lentiviral Vector Platform
1个月前
已完结
Advances in RNA therapy for the treatment of autoimmune diseases
1个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
1个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
1个月前
已完结
BCMA-CAR T-cells in a patient with relapsing idiopathic inflammatory myositis after CD19-CAR T-cells
1个月前
已完结
皖公网安备34019202002308
